Zim Laboratories Ltd

NSE:ZIMLABHealthcare

₹138.17−4.55%At closeAt close · Mon 19 Oct · ≈ AED 5.34 · Market cap $78.3M

INR billions	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	TTM	YoY
Revenue	3.1	3.3	4.0	3.7	3.7	3.7	4.0	+7.5%
Cost of revenue	1.6	1.6	3.1	1.8	3.0	3.1	2.6	−14.2%
Gross profit	1.5	1.7	0.9	1.9	0.7	0.6	1.3	+115.8%
Research & development	0.1	0.2	0.2	0.2	0.2	0.2	—	—
Selling, general & administrative	0.4	0.4	0.5	0.6	0.7	0.4	—	—
Selling & marketing	0.3	0.3	0.3	0.2	0.0	0.2	—	—
Operating expenses	0.5	0.6	0.6	0.8	0.5	0.6	1.3	+123.9%
Operating income	0.2	0.2	0.3	1.1	0.2	0.1	0.1	+36.1%
Interest expense	0.1	0.1	0.1	0.1	0.1	0.1	0.1	+4.6%
Interest income	0.0	0.0	0.0	0.0	0.0	0.0	0.0	−100.0%
Other income / expense	(0.1)	(0.0)	0.0	(0.9)	(0.0)	0.0	—	—
Pre-tax income	0.1	0.2	0.4	0.2	0.2	0.1	0.1	−38.2%
Income tax	0.0	0.1	0.1	0.1	0.1	0.0	0.0	−42.1%
Net income	0.1	0.1	0.2	0.2	0.1	0.1	0.0	−36.7%
Discontinued operations	0.0	0.0	0.0	0.0	0.0	0.0	—	—
Other net income adjustments	0.0	0.0	0.0	0.0	0.0	0.0	—	—
EPS, basic (per share)	1.50	2.99	5.01	3.54	2.50	1.19	0.83	−30.7%
EPS, diluted (per share)	1.50	2.99	5.01	3.54	2.50	1.19	0.83	−30.7%
EBITDA	0.4	0.5	0.6	0.5	0.5	0.3	0.3	+10.0%
Depreciation & amortization	0.2	0.2	0.2	0.2	0.2	0.2	—	—
Weighted average shares (shares)	48,783,333	48,725,814	48,725,814	48,718,644	48,661,000	49,060,000	—	—
Weighted average diluted shares (shares)	48,684,156	48,725,814	48,725,814	48,725,814	48,661,000	49,060,000	—	—
Gross margin	48.2%	50.5%	22.7%	50.6%	19.5%	16.7%	33.5%	+16.8 pts
Operating margin	8.0%	6.8%	7.8%	29.9%	5.4%	1.5%	1.9%	+0.4 pts
Net margin	2.4%	4.4%	6.1%	4.7%	3.3%	1.6%	0.9%	−0.6 pts

INR billionsUpdated Tue 30 Jun ·

ⓘ

Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.

TTM ends 2026-06-30 and uses four consecutive reported quarters.